Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Clin Pharmacol. 1985 Nov;20(5):511-3.

Double-blind trial of flurbiprofen and phenylbutazone in acute gouty arthritis.

Abstract

Flurbiprofen has been compared with phenylbutazone in a double-blind study involving 33 patients with acute gout. Patients received either flurbiprofen 400 mg daily for 48 h followed by 200 mg daily, or phenylbutazone 800 mg daily for 48 h followed by 400 mg daily. The drugs were of comparable efficacy, while side-effects were uncommon and relatively mild. Flurbiprofen appears to be a satisfactory alternative to phenylbutazone in the management of acute gouty arthritis.

PMID:
3907678
[PubMed - indexed for MEDLINE]
PMCID:
PMC1400723
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk